Part 2 of this series for Global Biosimilars Week dives into the complexities of payer and pharmacy benefit manager (PBM) ...

WELCOME BACK: Drugmakers’ top lobbying group is welcoming lawmakers back to town this week with a seven-figure ad blitz, ramping up pressure on Congress to enact a crackdown on pharmaceutical ...

But they don’t provide patient services or produce a tangible product — they simply ... employers and labor unions. The problem is as PBM profits soar, this success has not resulted in drug savings ...

The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

Pennsylvania State Grange. Matthew Espenshade is president of the Pennsylvania State Grange.

Rescription is the Anti-PBM solution that leverages the capabilities of its health ... and commitment to excellence. With a broad suite of services and specialties, differentiated capital structure, ...

Donald Trump will be the 47th President of the U.S. Not since 1892 has a President been elected to two non-consecutive terms, ...

Analyst Allen Lutz of Bank of America Securities reiterated a Sell rating on GoodRx Holdings (GDRX – Research Report), reducing the price ...

As health care costs escalate, a new survey reveals that 74% of employers are grappling with the impact on employee wages and benefits, with many anticipating further cost-shifting to their workforce.

Strengths: Robust Pharmacy Benefit Management and Health Insurance Services. Weaknesses: Vulnerability to Market Fluctuations and Regulatory Changes. Opportunities: Expansion into Emerging Markets ...

Optum Rx is rolling out a slate of new programs that seek to support independent pharmacies in managing costs and more ...